Terbinafine and leukopenia Patient Reports February 11, 2012

Terbinafine Side Effects Report #5082022-3
Terbinafine side effect was reported by a Health Professional from UNITED STATES on Aug 07, 2006. Female patient, 29 years of age, was diagnosed with systemic mycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: epidermal necrosis, erythema multiforme, leukopenia, rash erythematous, skin atrophy. Terbinafine dosage: 250 MG/DAY. Patient was hospitalized. Patient recovered.

Terbinafine Side Effects Report #5538346-6
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 29, 2007. Female patient was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: arthritis , leukopenia, myocardial infarction, systemic lupus erythematosus. Terbinafine dosage: unknown. Patient died.

Terbinafine Side Effects Report #5727201-4
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 29, 2007. Female patient was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: arthritis , leukopenia, myocardial infarction, systemic lupus erythematosus. Terbinafine dosage: unknown. Patient died.

Terbinafine Side Effects Report #5839360-3
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 25, 2008. Female patient was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: arthritis , leukopenia, myocardial infarction, systemic lupus erythematosus. Terbinafine dosage: unknown. Patient recovered.


Terbinafine Side Effects Report #5839483-9
Terbinafine side effect was reported by a Health Professional from UNITED KINGDOM on July 23, 2008. Female patient was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: arthritis , condition aggravated, cutaneous lupus erythematosus, erythema multiforme, leukopenia, myocardial infarction. Terbinafine dosage: unknown. Patient died on 01/01/2007.

Terbinafine Side Effects Report #5843938-0
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 23, 2008. Female patient was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: arthritis , erythema multiforme, leukopenia, myocardial infarction, rash macular, systemic lupus erythematosus, telangiectasia. Terbinafine dosage: unknown. Patient died.

Terbinafine Side Effects Report #5602083-X
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 07, 2008. Female patient was treated with Terbinafine. After drug was administered, patient experienced the following side effects: leukopenia, neutrophil count decreased, white blood cell count decreased. Terbinafine dosage: 250 MG;ORAL. During the same period patient was treated with ENALAPRIL MALEATE. Patient recovered.

Terbinafine Side Effects Report #5603312-9
Terbinafine side effect was reported by a Health Professional from UNITED KINGDOM on Jan 07, 2008. Female patient was treated with Terbinafine. After drug was administered, patient experienced the following side effects: leukopenia. Terbinafine dosage: 250 MG; ; ORAL. During the same period patient was treated with ENALAPRIL. Patient recovered.

Terbinafine Side Effects Report #5603417-2
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 08, 2008. Female patient was treated with Terbinafine. After drug was administered, patient experienced the following side effects: leukopenia, neutrophil count decreased. Terbinafine dosage: 250 MG; PO. During the same period patient was treated with ENALAPRIL MALEATE. Patient recovered.